Randomized, Double-blind, Placebo-controlled Trial of Z-100 Plus Radiation Therapy in Patients With Locally Advanced Cervical Cancer — A Phase III Trial
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 Jan 2019
Price : $35 *
At a glance
- Drugs Z 100 (Primary)
- Indications Cervical cancer; Squamous cell cancer
- Focus Registrational; Therapeutic Use
- Sponsors Zeria
- 08 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 04 Jun 2018 Planned number of patients changed from 600 to 780.
- 22 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov